1. A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma. Issue 3 (30th November 2018) Authors: Narita, Yoshitaka; Arakawa, Yoshiki; Yamasaki, Fumiyuki; Nishikawa, Ryo; Aoki, Tomokazu; Kanamori, Masayuki; Nagane, Motoo; Kumabe, Toshihiro; Hirose, Yuichi; Ichikawa, Tomotsugu; Kobayashi, Hiroyuki; Fujimaki, Takamitsu; Goto, Hisaharu; Takeshima, Hideo; Ueba, Tetsuya; Abe, Hiroshi; Tamiya, Taka... Journal: Neuro-oncology Issue: Volume 21:Issue 3(2019) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of haptoglobin genetic polymorphism with overall survival in advanced castration-resistant prostate cancer patients with personalized peptide vaccination. (7th November 2013) Authors: Komatsu, Nobukazu; Pang, Xiaoliang; Araki, Hiromitsu; Koda, Yoshiro; Soejima, Kimiko; Sasada, Tetsuro; Tashiro, Kosuke; Kuhara, Satoru; Itoh, Kyogo Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine‐treated ovarian cancer patients. Issue 4 (6th March 2020) Authors: Waki, Kayoko; Kawano, Kouichiro; Tsuda, Naotake; Komatsu, Nobukazu; Yamada, Akira Journal: Cancer science Issue: Volume 111:Issue 4(2020) Page Start: 1124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer. (4th March 2021) Authors: Waki, Kayoko; Yokomizo, Kanako; Yoshiyama, Koichi; Takamori, Shinzo; Komatsu, Nobukazu; Yamada, Akira Journal: Immunopharmacology and immunotoxicology Issue: Volume 43:Number 2(2021) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer. (4th March 2021) Authors: Waki, Kayoko; Yokomizo, Kanako; Yoshiyama, Koichi; Takamori, Shinzo; Komatsu, Nobukazu; Yamada, Akira Journal: Immunopharmacology and immunotoxicology Issue: Volume 43:Number 2(2021) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine. (10th June 2013) Authors: Yutani, Shigeru; Komatsu, Nobukazu; Matsueda, Satoko; Yoshitomi, Munehiro; Shirahama, Takahisa; Yamada, Akira; Itoh, Kyogo; Sasada, Tetsuro Other Names: Motoo Yoshiharu Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P0523PROTECTIVE ROLE OF REGULATORY B CELLS ON THE RENAL TISSUE REPAIRMEN AFTER ISCHEMIA REPERCUSSION INJURY. (6th June 2020) Authors: Yunosuke, Yokota; Kodama, Goh; Itou, Sakuya; Nakayama, Yosuke; Komatsu, Nobukazu; Mizoguchi, Atsushi; Fukami, Kei Journal: Nephrology dialysis transplantation Issue: Volume 35(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PD‐1 expression on peripheral blood T‐cell subsets correlates with prognosis in non‐small cell lung cancer. Issue 10 (23rd September 2014) Authors: Waki, Kayoko; Yamada, Teppei; Yoshiyama, Koichi; Terazaki, Yasuhiro; Sakamoto, Shinjiro; Matsueda, Satoko; Komatsu, Nobukazu; Sugawara, Shunichi; Takamori, Shinzo; Itoh, Kyogo; Yamada, Akira Journal: Cancer science Issue: Volume 105:Issue 10(2014:Oct.) Page Start: 1229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients. Issue 5 (26th April 2016) Authors: Iwasa, Satoru; Yamada, Yasuhide; Heike, Yuji; Shoji, Hirokazu; Honma, Yoshitaka; Komatsu, Nobukazu; Matsueda, Satoko; Yamada, Akira; Morita, Michi; Yamaguchi, Rin; Tanaka, Natsuki; Kawahara, Akihiko; Kage, Masayoshi; Shichijo, Shigeki; Sasada, Tetsuro; Itoh, Kyogo Journal: Cancer science Issue: Volume 107:Issue 5(2016) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients. (11th October 2015) Authors: Yutani, Shigeru; Ueshima, Kazuomi; Abe, Kazumichi; Ishiguro, Atsushi; Eguchi, Junichi; Matsueda, Satoko; Komatsu, Nobukazu; Shichijo, Shigeki; Yamada, Akira; Itoh, Kyogo; Sasada, Tetsuro; Kudo, Masatoshi; Noguchi, Masanori Other Names: Fridkis-Hareli Masha Academic Editor. Journal: Journal of immunology research Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗